Ignite Creation Date:
2024-05-06 @ 12:06 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01483144
Status:
COMPLETED
Last Update Posted:
2021-06-08
First Post:
2011-11-21
Brief Title:
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis FAP
Sponsor:
Cancer Prevention Pharmaceuticals Inc
Organization:
Cancer Prevention Pharmaceuticals Inc
Organization Data
Organization:
Cancer Prevention Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CPP-FAP-310
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cancer Prevention Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None